New pill could help severe asthma sufferers breathe easier
NCT ID NCT07532265
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called frevecitinib (KN-002) in 512 adults with severe asthma that is not well controlled by their current treatments. Participants will take one of three doses of the drug or a placebo daily for 12 weeks. The main goal is to see if the drug improves lung function and asthma control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research site
Lancaster, California, 93534, United States
-
Research site
San Jose, California, 95117, United States
-
Research site
Brandon, Florida, 33511, United States
-
Research site
Miami, Florida, 33137, United States
-
Research site
Tampa, Florida, 33607, United States
-
Research site
Chicago, Illinois, 60612, United States
-
Research site
Kansas City, Missouri, 66160, United States
-
Research site
St Louis, Missouri, 63141, United States
-
Research site
Charlotte, North Carolina, 28277, United States
-
Research site
Pittsburgh, Pennsylvania, 15213, United States
-
Research site
Rock Hill, South Carolina, 29732, United States
-
Research site
Dallas, Texas, 75225, United States
-
Research site
Houston, Texas, 77099, United States
-
Research site
San Antonio, Texas, 78258, United States
-
Research site
Williamsburg, Virginia, 23188, United States